Skip Nav DestinationYou do not currently have access to this content.
New labeling on TMP-SMX products warns of acute respiratory failure
July 1, 2021
from the Food and Drug Administration's Office of Pediatric Therapeutics and Center for Drug Evaluation and Research, Division of Pediatric and Maternal Health, Division of Anti-Infectives, and Office of Surveillance and Epidemiology
Article type: FDA Update